COST-PER-RESPONDER OF FIXED COMBINATION CALCIPOTRIOL plus BETAMETHASONE DIPROPIONATE AEROSOL FOAM VS OINTMENT IN PATIENTS WITH PSORIASIS VULGARIS IN THE UK

被引：0

作者：

Walker, A. ^{[1
]}

Oluwa, R. ^{[2
]}

Treloggen, Riis J. ^{[3
]}

机构：

[1] Univ Glasgow, Glasgow, Lanark, Scotland

[2] LEO Pharma, Hurley, England

[3] LEO Pharma, Ballerup, Denmark

来源：

VALUE IN HEALTH | 2017年 / 20卷 / 09期

关键词：

D O I：

10.1016/j.jval.2017.08.2395

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

PSS17

引用

页码：A803 / A804

页数：2

共 50 条

[1] COST-PER-RESPONDER (CPR) OF FIXED COMBINATION CALCIPOTRIOL PLUS BETAMETHASONE DIPROPIONATE CAL/BD CUTANEOUS FOAM VS. CAL/BD GEL IN PATIENTS WITH MILD TO MODERATE PSORIASIS VULGARIS
Bithal, N.
Oluwa, F.
Treloggen, J. R.
VALUE IN HEALTH, 2020, 23 : S734 - S734
[2] Efficacy of an Innovative Aerosol Foam Formulation of Fixed Combination Calcipotriol plus Betamethasone Dipropionate in Patients with Psoriasis Vulgaris
Queille-Roussel, Catherine
Olesen, Martin
Villumsen, John
Lacour, Jean-Philippe
CLINICAL DRUG INVESTIGATION, 2015, 35 (04) : 239 - 245
[3] Efficacy of an Innovative Aerosol Foam Formulation of Fixed Combination Calcipotriol plus Betamethasone Dipropionate in Patients with Psoriasis Vulgaris
Catherine Queille-Roussel
Martin Olesen
John Villumsen
Jean-Philippe Lacour
Clinical Drug Investigation, 2015, 35 : 239 - 245
[4] Fixed combination calcipotriol plus betamethasone dipropionate aerosol foam in the treatment of psoriasis vulgaris: rationale for development and clinical profile
Paul, Carle
Bang, Bo
Lebwohl, Mark
EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (01) : 115 - 121
[5] Superior efficacy of the fixed combination calcipotrene plus betamethasone dipropionate in a novel aerosol foam versus ointment in patients with psoriasis vulgaris
Koo, J.
Tyring, S.
Werschler, W. P.
Olesen, M.
Bruce, S.
Villumsen, J.
Bagel, J.
EXPERIMENTAL DERMATOLOGY, 2015, 24 (12) : 985 - 985
[6] Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam For Scalp Psoriasis
Anderko, Marian
Trivino, Francisco Jose Navarro
Sharples, Charlotte L.
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2019, 12 : 699 - 705
[7] A Cost-utility Analysis of Calcipotriol/Betamethasone Dipropionate Aerosol Foam versus Ointment for the Topical Treatment of Psoriasis Vulgaris in Sweden
Duvetorp, Albert
Levin, Lars-Ake
Engerstedt Mattsson, Emma
Ryttig, Lasse
ACTA DERMATO-VENEREOLOGICA, 2019, 99 (04) : 393 - 399
[8] Enhanced vasoconstrictor potency of the fixed combination calcipotriol plus betamethasone dipropionate in an innovative aerosol foam formulation vs. other corticosteroid psoriasis treatments
Queille-Roussel, C.
Bang, B.
Clonier, F.
Lacour, J. -P.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 (11) : 1951 - 1956
[9] COST PER RESPONDER ANALYSIS OF CALCIPOTRIOL PLUS BETAMETHASONE DIPROPIONATE AEROSOL FOAM VERSUS NON-BIOLOGIC SYSTEMIC THERAPY IN THE TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS
Becla, L.
Carrascosa, J. M.
Antunes, J. F.
Bewley, A. P.
Delgado Perala, M.
Charrua, M. F.
O'shaughnessy, S.
Treloggen, J. R.
Sawyer, L. M.
Cornic, L.
VALUE IN HEALTH, 2018, 21 : S425 - S425
[10] Editorial: fixed-dose combination calcipotriol/betamethasone dipropionate foam in the treatment of patients with psoriasis
Lebwohl, M.
Warren, R. B.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 : 3 - 4

← 1 2 3 4 5 →